Advertisement

PET-CT Findings in Head and Neck Cancer

  • Fani J. Vlachou
Chapter

Abstract

Multimodality imaging is not only the present but also the future of diagnostic imaging. PET/CT is a hybrid device, which has the capability to provide a combination of anatomical and functional imaging due to the high spatial resolution of CT and the molecular imaging of PET.

References

  1. 1.
    Agarwal V, Branstetter BF IV, Johnson JT (2008) Indications for PET/CT in the head and neck. Otolaryngol Clin N Am 41:23–49CrossRefGoogle Scholar
  2. 2.
    Grosu AL, Weber WA (2010) PET for radiation treatment planning of brain tumors. Radiother Oncol 96:325–327CrossRefGoogle Scholar
  3. 3.
    Funk GF (2012) Head and neck surgeon’s perspective on best practices for the use of PET/CT scans for the diagnosis and treatment of head and neck cancers, clinical challenges in otolaryngology. Arch Otoralyngol Head Neck Surg 138(8):748–751CrossRefGoogle Scholar
  4. 4.
    Lauren VZ, Wiggins RH (2012) A head and neck radiologist’s perspective on best practices for the usage of PET/CT scans for the diagnosis and treatment of head and neck cancers, clinical challenges in otolaryngology. Arch Otoralyngol Head Neck Surg 138(8):754–758CrossRefGoogle Scholar
  5. 5.
    Ha PK, Hdeib A, Goldenberg D et al (2006) The role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 132(1):12–16CrossRefGoogle Scholar
  6. 6.
    Rusthoven KE, Koshy M, Paulino AC et al (2004) The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor. Cancer 101(11):2641–2649CrossRefGoogle Scholar
  7. 7.
    Ahn PH, Garg MH (2008) Positron emission tomography/computed tomography for target delineation in head and neck cancers. In: Seminars in nuclear medicine, Department of Radiation Oncology, pp 141–147CrossRefGoogle Scholar
  8. 8.
    Souvatzoglou M, Grosu AL, Roper B, Krause BJ, Beck R, Reischl G, Picchio M, Machulla HJ, Wester HJ, Piert M (2007) Tumor hypoxia imaging with FAZA PET in head and neck cancer patients: a pilot study. Eur J Nucl Med Mol Imaging 34:1566–1575CrossRefGoogle Scholar
  9. 9.
    Kostakoglu L, Valk PE (2006) Assessment of treatment response by FDG-PET. Positron Emission Tomography. Springer, 405:387–389Google Scholar
  10. 10.
    Quon A, Fischbein NJ, Ross McDougal I, Le Q-T, Loo BW, Pinto H, Kaplan MJ (2007) Clinical role of F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma. J Nucl Med 48:58S–67SPubMedGoogle Scholar
  11. 11.
    Buchbender C, Heusner TA, Lauestein TC, Bockisch A, Antoch G (2012) Oncologic PET/MRI, Part1: tumors of the brain, head and neck, chest, abdomen and pelvis. J Nucl Med 53:1–11CrossRefGoogle Scholar
  12. 12.
    Marcus C, Ciarallo A, Tahari AK, Mena E, Koch W, Wahl RL, Kiess AP, Kang H, Subramaniam RM (2014) Head and neck PET/CT: therapy response interpretation criteria (hopkins criteria)-interreader reliability, accuracy, and survival outcomes. J Nucl Med 55:1411–1416CrossRefGoogle Scholar
  13. 13.
    Sjovall J, Bitze’n U, Kjelle’n E et al (2015) Qualitative interpretation of PET scans using a Likert scale to assess neck node response to radiotherapy in head and neck cancer. Eur J Nucl Med Mol Imaging 43:609–616CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Fani J. Vlachou
    • 1
  1. 1.Department of Nuclear MedicineHygeia HospitalAthensGreece

Personalised recommendations